Questions on sustainability of bio tech
15 April 2018
Analysts of Goldman Sachs are asking serious questions on the sustainability of the bio tech model. ‘Is curing patients a sustainable business model?’, they ask in a report entitle ‘The Genome Revolution’. More at CNBC.